Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Journal of Psychopharmacology (Oxford, England)|April 25, 2026
Preliminary evidence that serum interleukin-6 is a candidate biomarker of response to esketamine in treatment-resistant depressionMarco Colizzi, Elisa Morandin, Veronica Croccia, et al.
Psychiatry Research|July 13, 2015
Reliability and normative data of the Perceptual Aberration Scale in an Italian juvenile general population sampleLivia Fornasari, Angelo Picardi, Marco Garzitto, et al.
BMC Psychiatry|July 19, 2020
Relationship between parenting measures and parents and child psychopathological symptoms: a cross-sectional studyMonica Bellina, Silvia Grazioli, Marco Garzitto, et al.
Journal of Clinical Medicine|January 28, 2026
Effect of Specialized Psychiatric Assessment and Precision Diagnosis on Pharmacotherapy in Adults with Intellectual DisabilityMarta Basaldella, Michele Rossi, Marco Garzitto, et al.
International Journal of Women'S Health|July 15, 2021
Prenatal Stress and Psychiatric Symptoms During Early Phases of the COVID-19 Pandemic in ItalyChiara Colli, Chiara Penengo, Marco Garzitto, et al.
Journal of Affective Disorders|July 16, 2021
Psychometric properties of the Italian version of the Pandemic-Related Pregnancy Stress Scale (PREPS) and its correlation with anxiety and depressionChiara Penengo, Chiara Colli, Marco Garzitto, et al.
The American Journal on Addictions|October 31, 2025
Neurodevelopmental burden in young adults undergoing opioid substitution therapy: The role of inattentive and hyperactive/impulsive symptomsMaddalena Cesco, Marco Garzitto, Livia Pischiutta, et al.
Brain, Behavior, & Immunity - Health|December 11, 2025
Effects of palmitoylethanolamide in clinical high-risk for psychosis: A nonrandomized open-label trialRiccardo Bortoletto, Marco Garzitto, Marta Basaldella, et al.
Brain and Cognition|March 6, 2018
The mental simulation of state/psychological verbs in the adolescent brain: An fMRI studyBarbara Tomasino, Maria Nobile, Marta Re, et al.
Brain Sciences|January 8, 2025
The Endocannabinoid Activity Remodulation for Psychosis Liability in Youth (EARLY) Study: An Open-Label Feasibility Trial of Ultramicronized-Palmitoylethanolamide Oral Supplementation in Clinical High-Risk State for PsychosisRiccardo Bortoletto, Marco Garzitto, Fabiana Piscitelli, et al.
Pageof 5